Latest News for: ma'at

Edit

MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft versus Host Disease (Maat Pharma SA)

Public Technologies 18 Mar 2025
Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients ... 18, 2025 at 17.07.31.533.
Edit

MaaT Pharma Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for MaaT013 (Maat Pharma SA)

Public Technologies 11 Mar 2025
This approval marks a major regulatory milestone towards the submission of our Marketing Authorization dossier with the EMA," said Gianfranco Pittari, MD, PhD, Chief Medical Officer at MaaT Pharma.
  • 1
×